Related references
Note: Only part of the references are listed.Molecular Pathogenesis of Hepatocellular Carcinoma
Helena Cornella et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Mitogen-activated protein kinases in hepatocellular carcinoma development
Lihua Min et al.
SEMINARS IN CANCER BIOLOGY (2011)
Molecular organization and dynamics of the melatonin MT1 receptor/RGS20/Gi protein complex reveal asymmetry of receptor dimers for RGS and Gi coupling
Pascal Maurice et al.
EMBO JOURNAL (2010)
In vitro and in vivo antitumor activity of melatonin receptor agonists
Lulu Mao et al.
JOURNAL OF PINEAL RESEARCH (2010)
Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)
Anna Leja-Szpak et al.
JOURNAL OF PINEAL RESEARCH (2010)
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer
Brittney Jung-Hynes et al.
JOURNAL OF PINEAL RESEARCH (2010)
MAPK signaling in inflammation-associated cancer development
Pengyu Huang et al.
PROTEIN & CELL (2010)
Current approach in the treatment of hepatocellular carcinoma
Luigi Rossi et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
Lulu Mao et al.
BREAST CANCER RESEARCH (2010)
A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production
P. J. Lardone et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
Stephen G. Grant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Molecular Mechanisms of Melatonin Anticancer Effects
Steven M. Hill et al.
INTEGRATIVE CANCER THERAPIES (2009)
Gene structures, biochemical characterization and distribution of rat melatonin receptors
Hirotaka Ishii et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2009)
Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells
Sara Carbajo-Pescador et al.
JOURNAL OF PINEAL RESEARCH (2009)
Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21CIP1/P27KIP1 pathways
Seong-Su Nah et al.
JOURNAL OF PINEAL RESEARCH (2009)
Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury
Emanuela Esposito et al.
JOURNAL OF PINEAL RESEARCH (2009)
Modulation of the cGMP signaling pathway by melatonin in pancreatic β-cells
Ina Stumpf et al.
JOURNAL OF PINEAL RESEARCH (2009)
Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer
Seong Soo Joo et al.
JOURNAL OF PINEAL RESEARCH (2009)
Melatonin signaling in mouse cerebellar granule cells with variable native MT1 and MT2 melatonin receptors
Marta Imbesi et al.
BRAIN RESEARCH (2008)
Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells
Irene Crespo et al.
FOOD AND CHEMICAL TOXICOLOGY (2008)
Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line
Javier Martin-Renedo et al.
JOURNAL OF PINEAL RESEARCH (2008)
Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice
B. B. Otalora et al.
JOURNAL OF PINEAL RESEARCH (2008)
MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation
C. Dominic Bondi et al.
JOURNAL OF PINEAL RESEARCH (2008)
Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat
Henrique Fillmann et al.
TOXICOLOGY (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors
Cyril D. Toma et al.
JOURNAL OF PINEAL RESEARCH (2007)
Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture
Ana Garcia-Navarro et al.
JOURNAL OF PINEAL RESEARCH (2007)
Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53
TC Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Functional MT1 and MT2 melatonin receptors in mammals
ML Dubocovich et al.
ENDOCRINE (2005)
Expression of membrane and nuclear melatonin receptors in mouse peripheral organs
L Naji et al.
LIFE SCIENCES (2004)
Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis
K Iskander et al.
CANCER RESEARCH (2004)
mRNA expression of nuclear receptor RZR/RORα, melatonin membrane receptor MT1, and hydroxindole-O-methyltransferase in different populations of human immune cells
D Pozo et al.
JOURNAL OF PINEAL RESEARCH (2004)
Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype
SYW Shiu et al.
JOURNAL OF PINEAL RESEARCH (2003)
MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells
L Yuan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins
ASL Chan et al.
CELLULAR SIGNALLING (2002)
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
SS Bacus et al.
ONCOGENE (2001)
Identification of the melatonin-binding site MT3 as the quinone reductase 2
O Nosjean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors
C Browning et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
